Sumitomo Mitsui Trust Group and Amova Asset Management Report 4.7% Ownership in 10x Genomics

Sumitomo Mitsui Trust Group, Inc. and Amova Asset Management Co., Ltd. have filed a Schedule 13G/A amendment to report their ownership in 10x Genomics, Inc. The filing indicates that both entities collectively own 4.7% of the Class A common stock of 10x Genomics, amounting to 5,381,219 shares. Sumitomo Mitsui Trust Group, Inc. holds 5,381,219 shares, while Amova Asset Management Co., Ltd. holds 5,376,883 shares. Both entities are classified as parent holding companies and non-U.S. institutions. The filing also includes details about their subsidiaries and their roles in the ownership structure. The amendment was signed by senior officials from both entities on October 27, 2025.